If both have been completed, no further action is required.
Why is the above information required?
2021 influenza vaccines will not be released to providers who fail to complete the NSW Health flu vaccine survey. The deadline for survey completion was 11 December 2020 – those who have not yet completed the survey must complete survey now.
Subsequent orders cannot be placed until immunisation providers confirm receipt of a vaccine delivery on the NSW Vaccine Centre webpage. This is to ensure NSW Health can account for all vaccinedose delivered to immunisation providers.
The Authorised Nurse Immuniser Policy Directive outlines the mandatory conditions which specially trained registered nurses and midwives must comply with to ensure effective and efficient immunisation service delivery.
Why is COVID-19 vaccine not included in the new legislation?
Inclusion of the COVID-19 vaccine under the Authority cannot occur until it has been listed in the Commonwealth Poisons Schedule as a poison or restricted substance. The Authority will be further updated when that occurs.
CESPHN scholarship for Authorised Nurse Immuniser course
Central and Eastern Sydney PHN is offering practice nurses the opportunity to apply for a 75 per cent* scholarship to complete The Benchmarque Group’s Immunisation Endorsement Program. This course is to become an authorised nurse immuniser in NSW and administer vaccinations independent of a medical officer, which will include COVID-19 vaccine. The Authority will be further updated to include the COVID-19 vaccine once it has been listed in the Commonwealth Poisons Schedule.
The Benchmarque Group’s Immunisation Endorsement Program course involves 112 hours of online study and assessment in addition to a half day workshop. The course is accredited by Health Education Services Australia (HESA) and conforms with the National Immunisation Education Framework for Health Professionals.
Upon completion of this course, registered nurses and midwives will have the qualification to administer vaccinations in NSW, independent of a medical officer, as per NSW Health Authority.
CESPHN invites registered nurses working in general practice in the CESPHN region to apply for a scholarship for the Benchmarque Immunisation Endorsement Program (full cost $567).
Eligibility criteria: registered nurses working in general practice within the CESPHN region, who have not completed the Authorised Nurse Immuniser qualification.
Recipients will be eligible for the following, upon successful completion of the course:
75 per cent of course fee reimbursement ($425) upon course completion prior to 31 March 2021
50 per cent of course fee reimbursement ($284) upon course completion prior to 30 June 2021
25 per cent of course fee reimbursement ($142) upon course completion prior to 31 December 2021
How to apply
Submit your application now to commence your course and receive the scholarship:
Once you have completed the Course in Immunisation Practice, you can then enrol in the Immunisation Endorsement Program which qualifies you as an Authorised Nurse Immuniser in NSW
For more information and resources on immunisation, read our latest Immunisation Weekly Update or contact firstname.lastname@example.org
MumBubVax is a new evidence-based communication package to use in primary care or maternity services. It aims to improve conversations about vaccination between health care providers and expectant parents and provides eLearning modules for providers and a website for expectant parents.
The MumBubVax eLearning modules aims to support healthcare providers in communicating confidently and effectively with expectant parents about vaccination during pregnancy and for babies after delivery.
The MumBubVax website for expectant parents is designed to support conversations about vaccination during pregnancy and for babies after delivery. This includes independently assessed information about influenza, pertussis and Hepatitis B vaccines included on the National Immunisation Program and answers to common questions.
The Australian Department of Health supports the package which can be used in primary care or maternity services.
Zostavax vaccine safety advisory
New TGA Safety Advice: Zostavax vaccine was published 22 December 2020 on the TGA website regarding Zostavax and risk of disseminated varicella zoster virus (vaccine strain) infection.
Zostavax is a live, attenuated varicella-zoster virus vaccine that is used to prevent shingles in older patient.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…